William,
I think the original question was regarding the best place to insert
disclaimer text in the 271, stating that the response was not a guarantee
of payment. Someone did suggest a suitable field for it, but it seems
unlikely that a provider (human) would ever see it there... unless they had
specifically programmed the receiving system to capture that text and
display or print it.
Disclaimers should be reserved for the truly unsophisticated user...
someone who is actually *likely* to make the error out of ignorance or
misunderstanding. A patient might make this mistake, and since the patient
is not a covered entity, you would have great flexibility with the
disclaimer text placement. (I recommend not bugging the doctors with this
stuff.)
Regards,
-Chris
At 07:01 PM 8/10/01 -0400, you wrote:
>Sandy Young, Joey Lawhorn and Christopher J. Feahr all tell Dana Grant
>that "section 1.3.10 [in the HIPAA IG ASC X12N 270/271 004010X092]
>encourages disclaimers to be outlined in the trading partner agreement."
>
>A na�ve question: how does every payer in the country maintain a trading
>partner agreement with potentially every provider they'll ever deal
>with?
>
>TPAs....oops, "companion documents" ... "should not be required for
>acceptance of a transaction as valid." The payer "may not reject the
>transaction merely because they cannot process an explicit request."
>
>William J. Kammerer
>Rachel Foerster & Associates, Ltd.
>
>
>
>
>**********************************************************************
>To be removed from this list, send a message to: [EMAIL PROTECTED]
>Please note that it may take up to 72 hours to process your request.
Christopher J. Feahr, OD Vision Data Standards Council
Executive Director http://visiondatastandard.org
Cell/Pager: 707-529-2268 [EMAIL PROTECTED]
**********************************************************************
To be removed from this list, send a message to: [EMAIL PROTECTED]
Please note that it may take up to 72 hours to process your request.
